BIOMAT Database Logo BIOMAT Database Logo

[Isoptin-Retard 240 mg in the treatment of mild and moderate arterial hypertension]. 1993

G G Arabidze, and A N Rogoza, and V V Dmitriev, and T V Metelitsa, and G Iu Domba, and V K Sitina

To elucidate a hypotensive effect of isoptin-retard in a dose 240 mg/day, 17 males with mild and moderate hypertension receiving the drug underwent 24-h monitoring by SpaceLabs 5300 and pressure loading. A significant lowering of both mean systolic and diastolic pressure was found both in daytime and at night. A hypotensive effect persisted for 2 months. No case of serious cardiovascular complications, of noticeable shifts in blood biochemistry was reported.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014700 Verapamil A calcium channel blocker that is a class IV anti-arrhythmia agent. Iproveratril,Calan,Cordilox,Dexverapamil,Falicard,Finoptin,Isoptin,Isoptine,Izoptin,Lekoptin,Verapamil Hydrochloride,Hydrochloride, Verapamil
D015924 Blood Pressure Monitors Devices for continuously measuring and displaying the arterial blood pressure. Monitors, Blood Pressure,Sphygmomanometers, Continuous,Blood Pressure Monitor,Continuous Sphygmomanometer,Continuous Sphygmomanometers,Monitor, Blood Pressure,Pressure Monitor, Blood,Pressure Monitors, Blood,Sphygmomanometer, Continuous

Related Publications

G G Arabidze, and A N Rogoza, and V V Dmitriev, and T V Metelitsa, and G Iu Domba, and V K Sitina
[Slow-release verapamil 240 mg and treatment of mild to moderate hypertension].
January 1989, Therapie,
G G Arabidze, and A N Rogoza, and V V Dmitriev, and T V Metelitsa, and G Iu Domba, and V K Sitina
[Isoptin SR-240 and SR-120 in ambulatory treatment of arterial hypertension].
January 1996, Przeglad lekarski,
G G Arabidze, and A N Rogoza, and V V Dmitriev, and T V Metelitsa, and G Iu Domba, and V K Sitina
[Use of isoptin SR-240 in treatment of hypertension].
December 1993, Wiadomosci lekarskie (Warsaw, Poland : 1960),
G G Arabidze, and A N Rogoza, and V V Dmitriev, and T V Metelitsa, and G Iu Domba, and V K Sitina
[Bopindolol in the treatment of mild and moderate arterial hypertension].
October 1988, Minerva cardioangiologica,
G G Arabidze, and A N Rogoza, and V V Dmitriev, and T V Metelitsa, and G Iu Domba, and V K Sitina
[Diltiazem 180 mg in delayed release formulation in mild and moderate arterial hypertension].
April 1995, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,
G G Arabidze, and A N Rogoza, and V V Dmitriev, and T V Metelitsa, and G Iu Domba, and V K Sitina
Systemic and arterial hemodynamic effects of nifedipine (20 mg) in mild-to-moderate hypertension.
January 1983, Hypertension (Dallas, Tex. : 1979),
G G Arabidze, and A N Rogoza, and V V Dmitriev, and T V Metelitsa, and G Iu Domba, and V K Sitina
[Tests for efficacy and tolerance of isoptin SR 240 in treatment of hypertension--BISON].
December 1993, Wiadomosci lekarskie (Warsaw, Poland : 1960),
G G Arabidze, and A N Rogoza, and V V Dmitriev, and T V Metelitsa, and G Iu Domba, and V K Sitina
Once daily 50 mg Atenolol in the treatment of mild and moderate hypertension.
October 1983, Singapore medical journal,
G G Arabidze, and A N Rogoza, and V V Dmitriev, and T V Metelitsa, and G Iu Domba, and V K Sitina
Double-blind comparison of amlodipine and nifedipine retard in the treatment of mild to moderate hypertension.
January 1994, Journal of human hypertension,
G G Arabidze, and A N Rogoza, and V V Dmitriev, and T V Metelitsa, and G Iu Domba, and V K Sitina
[Treatment of mild and moderate essential arterial hypertension with captopril].
June 1980, AMB : revista da Associacao Medica Brasileira,
Copied contents to your clipboard!